Effect of Hormone Replacement Therapy on Bone Mineral Density and Body Composition in Chinese Adolescent and Young Adult Turner Syndrome Patients

Effect of Hormone Replacement Therapy on Bone Mineral Density and Body Composition in Chinese Adolescent and Young Adult Turner Syndrome Patients

A longitudinal observational study was performed comparing BMD and body composition in Turner syndrome girls before and after 1 year of HRT treatment. Whole body BMD, femur neck BMD, total hip BMD, and lean mass were significantly increased, but there was no difference in fat mass, and lumbar spine...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Li Li, Xiu Qiu, Gendie E. Lash, Lianxiong Yuan, Zichao Liang, Li Liu
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Frontiers Media S.A. 2019-06-01
Reeks:	Frontiers in Endocrinology
Onderwerpen:	hormone replace therapy bone mineral density body composition turner syndrome China
Online toegang:	https://www.frontiersin.org/article/10.3389/fendo.2019.00377/full

Gelijkaardige items

Effects of Psychosomatic Mutual Aid Treatment on Anxiety and Depression in Turner Syndrome
door: Mudan Ye, et al.
Gepubliceerd in: (2021-05-01)

Effect of Growth Hormone and Estrogen Replacement Therapy on Bone Mineral Density in Women with Turner Syndrome: A Meta-Analysis and Systematic Review
door: Weronika Szybiak, et al.
Gepubliceerd in: (2023-09-01)

The pubertal development mode of Chinese girls with turner syndrome undergoing hormone replacement therapy
door: Song Guo, et al.
Gepubliceerd in: (2019-07-01)

Diagnostic and therapeutic considerations in Turner syndrome
door: Seung Yang
Gepubliceerd in: (2017-12-01)

Clinical Profile of Turner Syndrome: A Tertiary Center Experience
door: Dhanya Soodhana Mohan, et al.
Gepubliceerd in: (2023-03-01)

The Unusual Case of Fibroma of Tendon Sheath in a Young Girl with Turner Syndrome Undergoing Growth Hormone Treatment
door: Yong Hee Hong, et al.
Gepubliceerd in: (2021-03-01)

Are Young People with Turner Syndrome Who Have Undergone Treatment with Growth and Sex Hormones at Higher Risk of Metabolic Syndrome and Its Complications?
door: Mariola Krzyścin, et al.
Gepubliceerd in: (2024-05-01)

Effect of Growth Hormone Therapy on Adult Height of Children with Turner Syndrome
door: Ping-Yi Hsu, et al.
Gepubliceerd in: (2008-09-01)

Response to three years of growth hormone therapy in girls with Turner syndrome
door: Hong Kyu Park, et al.
Gepubliceerd in: (2013-03-01)

Growth hormone treatment in Turner's syndrome: A real world experience
door: Vijay Sheker Reddy Danda, et al.
Gepubliceerd in: (2017-01-01)

Concomitant occurrence of Turner syndrome and growth hormone deficiency
door: Jung Yu, et al.
Gepubliceerd in: (2016-11-01)

Body composition, but not insulin resistance, influences postprandial lipemia in patients with Turner's syndrome
door: Rodrigo de Azeredo Siqueira, et al.
Gepubliceerd in: (2020-08-01)

ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome
door: Renata C Scalco, et al.
Gepubliceerd in: (2019-12-01)

Incidence and risk factors of hearing loss in patients with Turner Syndrome
door: Huijia Lin, et al.
Gepubliceerd in: (2023-03-01)

Skeletal Characteristics of Children and Adolescents with Turner Syndrome
door: Masanobu Kawai, et al.
Gepubliceerd in: (2022-08-01)

Recombinant growth hormone therapy in children with Turner Syndrome in Korea: a phase III Randomized Trial
door: Jinsup Kim, et al.
Gepubliceerd in: (2021-12-01)

Height outcome of the recombinant human growth hormone treatment in Turner syndrome: a meta-analysis
door: Ping Li, et al.
Gepubliceerd in: (2018-04-01)

Factors associated with low bone mineral density in Turner syndrome: a multicenter prospective observational study
door: Kento Ikegawa, et al.
Gepubliceerd in: (2024-06-01)

The Interplay between Muscular Grip Strength and Bone Mineral Density with Consideration of Metabolic and Endocrine Parameters in Individuals with Turner Syndrome
door: Mariola Krzyścin, et al.
Gepubliceerd in: (2023-11-01)

BONE FRAGILITY IN TURNER SYNDROME: MECHANISMS AND PREVENTION STRATEGIES
door: Maria Felicia Faienza, et al.
Gepubliceerd in: (2016-04-01)

Response of children with Turner syndrome with different types of karyotype abnormalities to growth hormone treatment
door: Jung Eun Choi, et al.
Gepubliceerd in: (2024-10-01)

Growth velocity increase in children with Turner syndrome treated with growth hormone following a brief therapy interruption
door: Andrzej Kędzia, et al.
Gepubliceerd in: (2023-09-01)

Shereshevsky-Turner syndrome: Estrogen replacement therapy and cardiovascular risk factors
door: O A Yevstigneeva, et al.
Gepubliceerd in: (2017-10-01)

Spectrum of Turner's syndrome: Our experience
door: Padmaja Pendekanti, et al.
Gepubliceerd in: (2020-01-01)

Craniofacial Morphology in Children with Growth Hormone Deficiency and Turner Syndrome
door: Dorota Wójcik, et al.
Gepubliceerd in: (2020-02-01)

Rare presentation of neurofibromatosis and Turner syndrome in a pediatric patient
door: Natalie Gengel, et al.
Gepubliceerd in: (2017-06-01)

Delayed diagnosis of turner,s Syndrome:A problem in treatment of short stature
door: R Vakili
Gepubliceerd in: (2002-09-01)

Prevalence and management of hypertension in Turner syndrome: data from the International Turner Syndrome (I-TS) registry
door: Shani A D Mathara Diddhenipothage, et al.
Gepubliceerd in: (2025-01-01)

Adult height in Indian girls with turner syndrome treated with long-term growth hormone therapy — A Western India tertiary centre experience
door: Vaman Khadilkar, et al.
Gepubliceerd in: (2023-01-01)

Turner syndrome: searching for better outcomes
door: Adauto Versiani Ramos, et al.
Gepubliceerd in: (2008-01-01)

Growth in girls with Turner syndrome
door: Tsuyoshi Isojima, et al.
Gepubliceerd in: (2023-01-01)

CRANIOFACIAL ASPECTS IN TURNER SINDROME
door: Dana Maria Albulescu, et al.
Gepubliceerd in: (2023-03-01)

Turner’s Syndrome – genetic, diagnostic methods and clinical treatment
door: Aleksandra Łokczewska-Bojar, et al.
Gepubliceerd in: (2023-09-01)

Deficient knowledge in adult Turner syndrome care as an incentive to found Turner centers in Germany
door: Elin Kahlert, et al.
Gepubliceerd in: (2019-11-01)

Glucose Metabolism in Turner Syndrome
door: Lin Sun, et al.
Gepubliceerd in: (2019-02-01)

FSH may be a useful tool to allow early diagnosis of Turner syndrome
door: Stela Carpini, et al.
Gepubliceerd in: (2018-02-01)

Coexistence of Growth Hormone Deficiency and Pituitary Microadenoma in a Child with Unique Mosaic Turner Syndrome: A Case Report and Literature Review
door: Eu Gene Park, et al.
Gepubliceerd in: (2020-10-01)

Turner Syndrome
door: Ethel Gonzales Clemente, et al.
Gepubliceerd in: (2022-05-01)

Bone marrow aplasia associated with Turner syndrome in pediatric patients
door: Liliana Martínez Cárdenas, et al.
Gepubliceerd in: (2011-10-01)

No influence of parental origin of intact X chromosome and/or Y chromosome sequences on three-year height response to growth hormone therapy in Turner syndrome
door: Hye Jin Lee, et al.
Gepubliceerd in: (2014-09-01)